ST2 deficiency specifically in Treg cells increases CD8 T cell counts, Tbet/IFNγ expression, and Wilms Tumor 1 (WT1) tumoral specificity while decreasing CD8 T cell exhaustion to decrease AML growth. This evidence concerns the gene WT1 and acute myeloid leukemia.